Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dexcom Inc (NQ: DXCM )

78.10 +0.16 (+0.21%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dexcom Inc

< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
Comparing Fitbits To Medical Devices? This Company Says Things Aren't Even Close
The health and wellness industry focused on the well-being of the body, mind and spirit has captured the globe's attention. According to management consulting firm, Mckinsey & Co., the global wellness... 
Via Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $16,000 Today
DexCom (NASDAQ:DXCM) has outperformed the market over the past 5 years by 64.52% on an annualized basis producing an average annual return of 74.42%. Currently, DexCom has a market capitalization of... 
Via Benzinga
Relief May Soon Be On The Way For Diabetes Sufferers Weary Of Constant Pin Pricks, According To This Company
Last year was the 100th anniversary of the discovery of insulin, which was instrumental in improving people's lives around the world. 
Via Benzinga
7 Undervalued Penny Stocks to Buy for Massive Gains
These seven undervalued penny stocks each have the potential to pay off for investors down later down the road. 
Via InvestorPlace
What Are Whales Doing With DexCom
A whale with a lot of money to spend has taken a noticeably bearish stance on DexCom. Looking at options history for DexCom (NASDAQ:DXCM) we detected 25 strange trades. 
Via Benzinga
Read Here Why Did This Analyst Cut DexCom's Price Target
Via Benzinga
Dexcom Stock Ticks Lower On Mixed First-Quarter Report
Dexcom dipped on light first-quarter profit, though sales narrowly beat forecasts. 
Via Investor's Business Daily
Here's Why These 14 Companies Did A Stock Split In 2022
A stock split's main purpose is to make a company's shares more appealing to potential investors. By raising the number of outstanding shares, it improves a company's liquidity. Stock splits do not... 
Via Benzinga
Markets Rise Amid Strength In Tech, Software
U.S. indices finished Thursday’s trading session higher. Overall tech and software sector strength as well as strong first-quarter results from Mongodb Inc (NASDAQ: MDB) lifted markets higher for the... 
Via Benzinga
Dexcom to Showcase Expanded CGM Portfolio and Industry-leading Connectivity at 82nd Scientific Sessions of the American Diabetes Association
From DexCom, Inc.
Via Business Wire
Here's How Much You Would Have Made Owning DexCom Stock In The Last 15 Years
DexCom (NASDAQ:DXCM) has outperformed the market over the past 15 years by 22.06% on an annualized basis producing an average annual return of 28.95%. Currently, DexCom has a market capitalization of... 
Via Benzinga
DexCom Dispels Rumor of Active Merger Talks as Insulet Stock Drops
"Active conversations" about a merger are not presently taking place between DexCom Inc. (DXCM), 7.28 percent, and the S&P 500 
Via Best Stocks
Dexcom Pops After Insulet Buyout Rumor Shakes Up Diabetes Stocks
The deal would have been transformative, but may have limited teamwork in the space. 
Via Investor's Business Daily
Dexcom Issues Statement on Recent Market Speculation
From DexCom, Inc.
Via Business Wire
Norwegian Cruise Line And Caesars Entertainment Lead The S&P 500 Lower: Today's Winners And Losers
U.S. indices finished Tuesday's trading session lower amid a continued sell-off in stocks. 
Via Benzinga
How The Rumored Dexcom-Insulet Marriage Could Rock The Entire Diabetes Space
One analyst called the rumored deal "transformative," but says the timing is unfavorable. 
Via Investor's Business Daily
PODD Stock Pops 7% as DexCom Considers Insulet Corporation Acquisition
Insulet (PODD) stock is heading higher on Tuesday as investors react to reports that DexCom (DXCM) is considering acquiring the company. 
Via InvestorPlace
Dexcom In Talks To Acquire Insulet, Create a Giant In Diabetes Devices: Bloomberg
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on
Good morning, trader! We're jumping into trading on Tuesday with an overview of the biggest pre-market stock movers this morning! 
Via InvestorPlace
Dexcom Announces Upcoming Conference Presentation
From DexCom, Inc.
Via Business Wire
Stocks Near Pre-COVID Highs - Thursday, May 19
The S&P 500 is still up over 15% relative to its pre-COVID high, but as of yesterday’s close, 41.2% of S&P 500 members were below their respective pre-COVID highs as 26 members crossed below this... 
Via Talk Markets
Dexcom Announces Upcoming Conference Presentations
From DexCom, Inc.
Via Business Wire
If You Invested $1000 In DexCom 10 Years Ago, Here's How Much You Would Have Today
DexCom (NASDAQ:DXCM) has outperformed the market over the past 10 years by 32.66% on an annualized basis producing an average annual return of 44.4%. Currently, DexCom has a market capitalization of... 
Via Benzinga
Stock Market Volatile; Apple, Facebook, Amazon Are Key Earnings, Tesla CEO Elon Musk Buys Twitter: Weekly Review
The Nasdaq hit its lowest level since 2020. Apple and Facebook led key earnings. 
Via Investor's Business Daily
Dexcom Updates First Quarter 2022 Conference Call for April 28, 2022 at 5:30 p.m. Eastern Time
From DexCom, Inc.
Via Business Wire
Recap: DexCom Q1 Earnings
DexCom (NASDAQ:DXCM) reported its Q1 earnings results on Thursday, April 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings DexCom missed estimated earnings by... 
Via Benzinga
Dexcom Reports First Quarter 2022 Financial Results
From DexCom, Inc.
Via Business Wire
Insulet Highlights New Data For Omnipod 5 System For Type 1, Type 2 Diabetes
Insulet Corporation (NASDAQ: PODD) unveiled study results for the new Omnipod 5 automated insulin delivery system in type 1 and type 2 diabetes patients. Paired with... 
Via Benzinga
DexCom Showcases Expanded CGM Portfolio at International ATTD Conference, Offering More Choice to People With Diabetes
From DexCom, Inc.
Via Business Wire
Markets Fall Sharply Amid Ongoing Rate Hike Concerns
The S&P 500 traded lower for the third week in a row as investors brace for a potential 0.5% interest rate hike by the Federal Reserve. U.S. indices traded sharply lower... 
Via Benzinga
< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.